scholarly journals 76. In Vivo Suppression of Cytotoxic T Cell Responses by CD4+ Regulatory T Cells Activated by Hepatic Gene Transfer

2006 ◽  
Vol 13 ◽  
pp. S32
Author(s):  
Lixin Wang ◽  
Eric Dobrzynski ◽  
Julie Fitzgerald ◽  
Ou Cao ◽  
Roland W. Herzog
2013 ◽  
Vol 191 (4) ◽  
pp. 2009-2017 ◽  
Author(s):  
Anusha-Preethi Ganesan ◽  
Magnus Johansson ◽  
Brian Ruffell ◽  
Adam Beltran ◽  
Jonathan Lau ◽  
...  

2013 ◽  
Vol 191 (10) ◽  
pp. 5319-5319 ◽  
Author(s):  
Anusha-Preethi Ganesan ◽  
Magnus Johansson ◽  
Brian Ruffell ◽  
Adam Yagui-Beltrán ◽  
Jonathan Lau ◽  
...  

1979 ◽  
Vol 149 (1) ◽  
pp. 150-157 ◽  
Author(s):  
P C Doherty ◽  
J C Bennink

BALB/c (H-2Kd-Dd) spleen and lymph node populations were specifically depleted of alloreactive potential by filtration through H-2 different, irradiated recipients. These negatively selected T cells were then stimulated with vaccinia virus in mice expressing the foreign H-2 determinants encountered previously in the filter environment. Strong virus-immune cytotoxic T-cell responses were seen in the context of H-2Kk and H-2Ks, but not 2H-2Kb. The T cells generated were not cross-reactive for the H-2Kk and H-2Kd alleles, and responsiveness was independent of concurrent presence of effector populations operating at H-2D. These findings are consisent with the idea that recognition is mediated via a complex receptor, part of which is specific for virus and part for self H-2. The capacity to interact with allogeneic, virus-infected cells may then reflect aberrant recognition of a virus-H-2-antigen complex by this single, large binding site. For instance, the T cell which would normally recognize H-2Kd-virus x, or H-2Dd-minor histocompatibility antigen Z, may now show specificity for H-2Kk-vaccinia virus. Implications for both the selective role of the thymus and for mechanisms of tolerance are discussed.


Blood ◽  
2008 ◽  
Vol 111 (7) ◽  
pp. 3546-3552 ◽  
Author(s):  
Christian Schütz ◽  
Martin Fleck ◽  
Andreas Mackensen ◽  
Alessia Zoso ◽  
Dagmar Halbritter ◽  
...  

Abstract Several cell-based immunotherapy strategies have been developed to specifically modulate T cell–mediated immune responses. These methods frequently rely on the utilization of tolerogenic cell–based antigen-presenting cells (APCs). However, APCs are highly sensitive to cytotoxic T-cell responses, thus limiting their therapeutic capacity. Here, we describe a novel bead-based approach to modulate T-cell responses in an antigen-specific fashion. We have generated killer artificial APCs (κaAPCs) by coupling an apoptosis-inducing α-Fas (CD95) IgM mAb together with HLA-A2 Ig molecules onto beads. These κaAPCs deplete targeted antigen-specific T cells in a Fas/Fas ligand (FasL)–dependent fashion. T-cell depletion in cocultures is rapidly initiated (30 minutes), dependent on the amount of κaAPCs and independent of activation-induced cell death (AICD). κaAPCs represent a novel technology that can control T cell–mediated immune responses, and therefore has potential for use in treatment of autoimmune diseases and allograft rejection.


1996 ◽  
Vol 8 (4) ◽  
pp. 457-465 ◽  
Author(s):  
Jean-Pierre Sauzet ◽  
Helene Gras-Masse ◽  
Jean-Gerard Guillet ◽  
Elisabeth Gomard

Sign in / Sign up

Export Citation Format

Share Document